user

NATURAL INTERFERON-ALPHA IN COMBINATION WITH MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA STAGE-II AND STAGE-III - A RANDOMIZED STUDY FROM THE MYELOMA GROUP OF CENTRAL SWEDEN

被引：0
|
作者：
OSTERBORG, A
BJORKHOLM, M
BJOREMAN, M
BRENNING, G
CARLSON, K
CELSING, F
GAHRTON, G
GRIMFORS, G
GYLLENHAMMAR, H
HAST, R
JOHANSSON, B
JULIUSSON, G
JARNMARK, M
KIMBY, E
LERNER, R
LINDER, O
MERK, K
NILSSON, B
OHRLING, M
PAUL, C
SIMONSSON, B
SMEDMYR, B
SVEDMYR, E
STALFELT, AM
STRANDER, H
UDEN, AM
OSBY, E
MELLSTEDT, H
机构：
[1] KAROLINSKA HOSP,RADIUM HEMMET,DEPT ONCOL,S-10401 STOCKHOLM,SWEDEN
[2] KAROLINSKA HOSP,DEPT BIOSTAT,S-10401 STOCKHOLM 60,SWEDEN
[3] KAROLINSKA HOSP,DEPT MED,S-10401 STOCKHOLM 60,SWEDEN
[4] DANDERYD HOSP,DEPT MED,STOCKHOLM,SWEDEN
[5] HUDDINGE HOSP,DEPT MED,S-14186 HUDDINGE,SWEDEN
[6] SODER SJUKHUSET,DEPT MED,STOCKHOLM,SWEDEN
[7] ACAD HOSP UPPSALA,DEPT MED,S-75014 UPPSALA,SWEDEN
[8] OREBRO MED CTR HOSP,DEPT MED,OREBRO,SWEDEN
来源：
BLOOD | 1993年 / 81卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1428 / 1434
页数：7
相关论文
共 50 条
  • [1] MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE PLUS HUMAN ALPHA INTERFERON THERAPY IN PATIENTS WITH MULTIPLE-MYELOMA, STAGE-II AND STAGE-III
    BJORKHOLM, M
    MELLSTEDT, H
    OSTERBORG, A
    BJOREMAN, M
    LERNER, R
    MERK, K
    BRENNING, G
    OHRLING, M
    GAHRTON, G
    SIMONSSON, B
    GRIMFORS, G
    SMEDMYR, B
    GYLLENHAMAR, H
    STALFELT, A
    HAST, R
    STRANDER, H
    JULIUSSON, G
    SVEDMYR, E
    JARNMARK, M
    UDEN, A
    KILLANDER, A
    WADMAN, B
    KIMBY, E
    OSBY, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 : S51 - S52
  • [2] ORAL VERSUS INTRAVENOUS MELPHALAN AND PREDNISONE TREATMENT IN MULTIPLE-MYELOMA STAGE-II - A RANDOMIZED STUDY FROM THE MYELOMA GROUP OF CENTRAL SWEDEN
    OSTERBORG, A
    AHRE, A
    BJORKHOLM, M
    BJOREMAN, M
    BRENNING, G
    GAHRTON, G
    GRIMFORS, G
    GYLLENHAMMAR, H
    HAST, R
    JOHANSSON, B
    JULIUSSON, G
    JARNMARK, M
    KILLANDER, A
    KIMBY, E
    LERNER, R
    NILSSON, B
    PAUL, C
    SIMONSSON, B
    STALFELT, AM
    SMEDMYR, B
    SVEDMYR, E
    UDEN, AM
    WADMAN, B
    OSBY, E
    MELLSTEDT, H
    [J]. ACTA ONCOLOGICA, 1990, 29 (06) : 727 - 731
  • [3] MANAGEMENT OF STAGE-II AND STAGE-III MULTIPLE-MYELOMA WITH MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE AND BCNU (PROTOCOL M-2)
    MONTALBAN, C
    SEVILLA, F
    ZAPATERO, A
    BLANCO, L
    SABAN, J
    SERRANO, M
    RIOS, MS
    [J]. REVISTA CLINICA ESPANOLA, 1985, 176 (08): : 392 - 395
  • [4] ALTERNATING COMBINATION CHEMOTHERAPY (VMCP/VBAP) IS NOT SUPERIOR TO MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA PATIENTS STAGE-III - A RANDOMIZED STUDY FROM MGCS
    OSTERBORG, A
    AHRE, A
    BJORKHOLM, M
    BJOREMAN, M
    BRENNING, G
    GAHRTON, G
    GYLLENHAMMAR, H
    JOHANSSON, B
    JULIUSSON, G
    JARNMARK, M
    KILLANDER, A
    KIMBY, E
    LERNER, R
    NILSSON, B
    PAUL, C
    SIMONSSON, B
    STALFELT, AM
    STRANDER, H
    SMEDMYR, B
    SVEDMYR, E
    UDEN, AM
    WADMAN, B
    WEDELIN, C
    MELLSTEDT, H
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 43 (01) : 54 - 62
  • [5] INTERFERON-ALPHA-2A MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE IN PREVIOUSLY UNTREATED PATIENTS WITH MULTIPLE-MYELOMA
    MONTUORO, A
    DEROSA, L
    DEBLASIO, A
    PACILLI, L
    PETTI, N
    DELAURENZI, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (03) : 365 - 368
  • [6] MELPHALAN AND PREDNISONE - EFFECTIVE COMBINATION FOR TREATMENT OF MULTIPLE-MYELOMA
    COSTA, G
    ENGLE, RL
    SCHILLING, A
    CARBONE, P
    KOCHWA, S
    NACHMAN, RL
    GLIDEWELL, O
    [J]. AMERICAN JOURNAL OF MEDICINE, 1973, 54 (05): : 589 - 599
  • [7] EFFECTIVENESS OF 2-STAGE TREATMENT OF MULTIPLE-MYELOMA WITH MELPHALAN AND WITH MELPHALAN IN COMBINATION WITH CYCLOPHOSPHAMIDE, CARMUSTINE, VINCRISTINE AND PREDNISONE
    SNIGUROWICZ, J
    KRAJ, M
    ROSTKOWSKA, J
    MAJ, S
    MARIANSKA, B
    MENDEK, E
    ROSZKOWSKI, S
    KILIAN, Z
    KOLAKOWSKI, L
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1981, 29 (02) : 145 - 153
  • [8] A RANDOMIZED TRIAL OF MELPHALAN AND PREDNISONE VERSUS MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, MECCNU, AND VINCRISTINE IN UNTREATED MULTIPLE-MYELOMA
    PAVLOVSKY, S
    SASLAVSKY, J
    PINTO, MT
    PALMER, L
    CURUCHET, M
    LEIN, JM
    GARAY, G
    DRAGOSKY, M
    QUIROGAMICHEO, E
    HUBERMAN, AB
    PIZZOLATTO, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) : 836 - 840
  • [9] A COMPARISON OF POLYCHEMOTHERAPY AND MELPHALAN PREDNISONE FOR PRIMARY REMISSION INDUCTION, AND INTERFERON-ALPHA FOR MAINTENANCE TREATMENT, IN MULTIPLE-MYELOMA - A PROSPECTIVE TRIAL OF THE GERMAN MYELOMA TREATMENT GROUP
    PEEST, D
    DEICHER, H
    COLDEWEY, R
    LEO, R
    BARTL, R
    BARTELS, H
    BRAUN, HJ
    FETT, W
    FISCHER, JT
    GOBEL, B
    HARMS, P
    HENKE, R
    HOFFMANN, L
    KREUSER, ED
    MAIER, WD
    MEIER, CR
    OERTEL, J
    PETIT, M
    PLANKER, M
    PLATZECK, C
    RESPONDEK, M
    SCHAFER, E
    SCHUMACHER, K
    STENNES, M
    STENZINGER, W
    TIRIER, C
    WAGNER, H
    WEH, HJ
    VONWUSSOW, P
    WYSK, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (02) : 146 - 151
  • [10] INITIAL VERSUS DEFERRED MELPHALAN-PREDNISONE THERAPY FOR ASYMPTOMATIC MULTIPLE-MYELOMA STAGE-I - A RANDOMIZED STUDY
    HJORTH, M
    HELLQUIST, L
    HOLMBERG, E
    MAGNUSSON, B
    RODJER, S
    WESTIN, J
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1993, 50 (02) : 95 - 102
12345